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responsible every year for nearly half amillion deaths, and an estimated
219 million clinical cases, globally [1]. The devastating short-term ef-
fects that an acute malarial infection can have on any given individual
have been historically well characterized, and there are also abundant
data on the subacute and chronic sequelae derived from severemalarial
episodes, which are understandable in the context of the sudden and
profound insult that such an aggressive infection may have in the cen-
tral nervous system and other key organs [2]. However, much scarcer
information exists regarding other more subtle or prolonged deleteri-
ous effects of malarial infection and disease on well-being, beyond its
acute phase, particularly in regard to common mental disorders
(CMD) and neuro-psychiatric health.
In this recent article of EBioMedicine [3] Rachel Jenkins and col-
leagues explore the three-way relationship between malaria, mental
disorders and immunity in a representative sample of adults randomly
selected from the Kombewa Health and Demographic Surveillance sys-
tem running in Kisumu, a highly malaria-endemic county located in
Western Kenya [4]. To do so, authors applied a myriad of validated
structured questionnaires designed to assess mental health and col-
lected blood samples of the studied individuals to confirm malaria
parasitaemia and test for common markers of immune function (CD4/
CD3 ratio, CD4 counts, IL-1β, IL-6, IL-8, and IL-10, TNF-β, TNF-α). Al-
though no associations were found between malaria and psychotic
symptoms, their results confirm a statistically significant association be-
tween malaria and CMD (OR 1.7, p= 0.014), a heterogeneous group of
distress states which typically manifest with anxiety, depressive and
unexplained somatic symptoms. Their results also hint at the potential
mediating role that the cytokine TNF-α may play in this association.
The association betweenmental health and non-communicable dis-
eases has beenwidely studied [5],with evidence of inflammation signif-
icantly contributing to the pathogenesis of major psychiatric disorders
(including depression [6] or schizophrenia [7], among others), and the
inflammasome -a multiprotein oligomer responsible for the activation
of inflammatory responses- proposed as a central mediator [8]. Con-
versely, the association between mental health and communicableDOI of original article: https://doi.org/10.1016/j.ebiom.2018.11.064.
⁎ Corresponding author at: Barcelona Institute for Global Health (ISGlobal) - Hospital
Clínic, Universitat de Barcelona, Rosselló 132, 5th floor, 08036 Barcelona, Spain.
URL's: rosauro.varo@isglobal.org (R. Varo), quique.bassat@isglobal.org (Q. Bassat).
https://doi.org/10.1016/j.ebiom.2019.01.008
2352-3964/© 2019 The Authors. Published by Elsevier B.V. This is an open access article underperhaps with the exception of some chronic infections such as HIV [9].
Findings reported in this study are of public health relevance, as they
propose for the first time a solid association between malaria infection
and CMD, while venturing a hypothetical cytokine pathway for such
an association. The association between TNF-α and depression has
been previously described and may be explained by its influence in
the hypothalamo-pituitary-adrenocortical axis, neuronal serotonin
transporters and in the indoleamine 2,3-dioxygenase pathway [10]. Ad-
ditionally, TNF-α may play a dual role in both the pathogenesis of and
protection against malaria, although the actual implication of this cyto-
kine in the course of disease has not been fully understood [11]. In fact,
anti-TNF therapies have been tested as adjuvant therapies in severema-
laria but have shown no effect in its prognosis [12].
In spite of its large sample size (n = 1158) and high consent rates
(97.2% for the interviews, 91.4% for the blood samples), factors for
which authors are to be praised, this study has important limitations
that need to be highlighted. First, it is possible that some of the conclu-
sions derive from chancefindings, due to themultiple comparisons con-
ducted. Second, concomitant conditions such as anemia or HIV, both
highly prevalent in the area, could have acted as confounders of the as-
sociation, and would need to be determined in future studies. Third, a
more comprehensive approach to understanding the immune response
is needed, including both the cellular and humoral components, and
with a longitudinal design. Finally, malaria infections may lead to a
wide spectrum of clinical symptomatology, ranging from pure asymp-
tomatic carriage of parasites, to life-threatening disease [13]. Thus, one
should avoid talking of malaria as a single clinical entity. It is probable
that adults in this highly-endemicmalarious setting have acquired a sig-
nificant amount of immunity and tolerance to the infection, allowing
them to carry malaria parasites without clinical expression, something
that undermines some of the author's hypotheses regarding the causal
relationship. Understanding the role of such asymptomatic infections,
as opposed to those with overt clinical symptoms (and its different clin-
ical phenotypes), and how theymay differentially expose the individual
to the risk of developing mental illness is necessary and would require
more precisely designed studies.
This study raises many questions and opens highly relevant gate-
ways that need to be further substantiated with additional research.
The first critical issue is that for these findings to unequivocally support
the author's conclusions, they need to be replicated in other malaria-the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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conditions (i.e. involving other malaria species and other intensity of
transmission scenarios). A wider use of the mental health screening
tools used here should therefore be encouraged, not only for the pur-
poses of replication, but also to more widely ascertain mental health
problems at the population level of low-income settings, an area unfor-
tunately so far neglected [14]. Second, due to its cross-sectional nature,
and although authors venture some hypotheses on how malaria could
lead to depression or vice versa, inference on directional causality is im-
possible. To further understand causal relations, prospective epidemio-
logical studies following cohorts of population at risk of acquiring
malaria should be established, and repeatedly evaluated to record
both their malaria infection status and the incidence of newly acquired
mental health problems. Additionally, by selectively inducing some of
the conditions under consideration, or activating some of the inflamma-
tory pathways proposed, research with animal models could experi-
mentally confirm some of these findings. Other areas warranting
further research include the impact of malaria elimination campaigns
on the mental health of both adults and children in endemic areas;
and possible target areas for preventive or therapeutic interventions
to avoid incident mental health problems in malaria endemic areas.
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